page_banner

Company News

  • Ornamentum deprehensio Urothelial Cancri fuit recognitio ...

    Diluculo Maio 2023, TAGMe DNA Methylation Detection Kit(qPCR) pro Urothelial Cancer independenter a Shanghai Epiprobe Biotechnologia Co., Ltd, adeptus "Breakper Fabricam Designationem" ab US FDA obtinuit.US FDA Breakthrough Devices Programma studet curare promovere ...
    Lege plus
  • TAGMe DNA Methylation Detection Kits (qPCR) for...

    Solutio in cancro endometriali, cancrum tollendo in stadio laesionum precancium.Cancer endometrialis est unus e tribus carinis malignis maioribus in gynecologia.Cancer endometrialis est inter carros malignos maxime communes in systemate generationis feminae, ranki...
    Lege plus
  • Baidu Salus et Epiprobe cooperative promovent exsecutionem primi pan-cancri protegendo

    Baidu Salutem et Epiprobe cooperative promovent...

    Oct. 30, 2022, Baidu Salus Internet Hospitalis (retulit "Baidu Health") et Shanghai Epiprobe Biotechnologia Co., Ltd. (relatum "Epiprobe") opportuna denuntiavit cooperationem ut pan-cancer primos protegendo in clinicis et communibus sanitatis canales duri...
    Lege plus
  • Epiprobe tres cancri methylationem detectionis rhoncus quam EU CE consecuti sunt certificatione

    Methylationis cancri deprehensio epiprobe tria k...

    Die 8 mensis Maii anno 2022, Epiprobe nuntiavit suam independenter enucleasse tres methylationis cancri detectionis kits: TAGMe DNA Methylation Detection Kits (qPCR) Cancri cervicali, TAGMe DNA Methylation Detection Kits (qPCR) pro Fine...
    Lege plus
  • Epiprobe completa fere RMB 100 decies centena serie B nummaria

    Epiprobe RMB 100 decies centena fere Se ...

    Nuper Shanghai Epiprobe Biotechnologia Co, Ltd. (referre "Epiprobam") pronuntiavit RMB 100 decies fere complesse in serie B nummorum, quae communi investitura capitis industrialis, regimen obsidionis platfor ...
    Lege plus